Identification of the hyaluronic acid pathway as a therapeutic target for facioscapulohumeral muscular dystrophy
Open Access
- 6 December 2019
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 5 (12) , eaaw7099
Abstract
Inhibition of HA synthesis blocks DUX4-induced pathologies.Keywords
Funding Information
- National Institute of Child Health and Human Development
- FSH Society
This publication has 50 references indexed in Scilit:
- Facioscapulohumeral Muscular Dystrophy2017
- Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damageHistochemistry and Cell Biology, 2016
- Expression of FSHD‐related DUX4‐FL alters proteostasis and induces TDP‐43 aggregationAnnals of Clinical and Translational Neurology, 2015
- Dominant Lethal Pathologies in Male Mice Engineered to Contain an X-Linked DUX4 TransgeneCell Reports, 2014
- Hyaluronan: Biosynthesis and signalingBiochimica et Biophysica Acta (BBA) - General Subjects, 2014
- Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunctionFree Radical Biology and Medicine, 2012
- DUX4 Activates Germline Genes, Retroelements, and Immune Mediators: Implications for Facioscapulohumeral DystrophyDevelopmental Cell, 2012
- DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53‐dependent myopathy in vivoAnnals of Neurology, 2010
- Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD‐dependent genesProteomics, 2006
- Hyaluronan Binding Protein 1 (HABP1)/C1QBP/p32 Is an Endogenous Substrate for MAP Kinase and Is Translocated to the Nucleus upon Mitogenic StimulationBiochemical and Biophysical Research Communications, 2002